Tabrizi, Mina

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 155

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

Ghaleiha, A., Entezari, N., Modabbernia, A., Najand, B., Askari, N., Tabrizi, M., Ashrafi, M., Hajiaghaee, R., & Akhondzadeh, S. (2013) · Journal of Psychiatric Research

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 152

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology

Ovarian function and disordersTreatment of Major Depression

Cited by 116

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

Khodaie-Ardakani, M.-R., Mirshafiee, O., Farokhnia, M., Tajdini, M., Hosseini, S.-M.-R., Modabbernia, A., Rezaei, F., Salehi, B., Yekehtaz, H., Ashrafi, M., et al. (2014) · Psychiatry Research

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 104

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder

Heidari, M., Zarei, M., Hosseini, S. M. R., Taghvaei, R., Maleki, H., Tabrizi, M., Fallah, J., & Akhondzadeh, S. (2014) · International Clinical Psychopharmacology

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 48

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial

Zarinara, A., Mohammadi, M., Hazrati, N., Tabrizi, M., Rezazadeh, S., Rezaie, F., & Akhondzadeh, S. (2010) · Human Psychopharmacology: Clinical and Experimental

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 44

Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study

Jafarinia, M., Mohammadi, M., Modabbernia, A., Ashrafi, M., Khajavi, D., Tabrizi, M., Yadegari, N., & Akhondzadeh, S. (2012) · Human Psychopharmacology: Clinical and Experimental

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 42

Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

Abbasi, S.-H., Heidari, S., Mohammadi, M.-R., Tabrizi, M., Ghaleiha, A., & Akhondzadeh, S. (2011) · Child Psychiatry & Human Development

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 34